Global Oral Anti-Diabetes Drugs Market


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 330

  • Format: PPT, PDF

Global Oral Anti-diabetes Drugs Market: Segmented by Drugs (Biguanides, Alpha-glucosidase inhibitors, Dopamine-D2 receptor agonists, Sodium-glucose Cotransport -2 (SGLT-2) inhibitor, Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors, Sulfonylureas, and Meglitinides), and by Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and Latin America) – Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The global oral anti-diabetes drugs market size stood at around USD 39.2 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.

Market Drivers

Increasing obese population and changing lifestyle are the factors projected to boost market growth. Advancements in technologies and reimbursement for medicines are anticipated to fuel the growth of the oral anti-diabetes drug market in the next few years. Moreover, rising incidence of diabetes is expected to increase demand for oral anti-diabetes drugs. However, ongoing research on diabetic treatment and high market potential are expected to create opportunities in the oral anti-diabetes market in the near future.

  1. Global Oral Anti-diabetes Drugs Market Overview………………………………………..
    1. Market Size
  2. Market Growth Drivers……………………………………………………..……………….
    1. Growing geriatric population
    2. Rise in cases of diabetes
    3. Growing government initiatives
  3. Oral Anti-diabetes Drugs Market Segmentation…..……………………………………….
    1. By Drugs
      1. Biguanides
      2. Alpha-glucosidase inhibitors
      3. Dopamine-D2 receptor agonists
      4. Sodium-glucose Cotransport -2 (SGLT-2) inhibitor
      5. Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors
      6. Sulfonylureas
      7. Meglitinides
    2. By Geography
      1. North America Market Analysis
      2. Europe Market Analysis
      3. Asia-Pacific Market Analysis
      4. Middle-East and Africa Market Analysis
      5. Latin America Market Analysis
  4. Anti-Diabetes Major Drugs Market Share……………………………………………….
    1. Key Findings
    2. Market Analysis, Insights and Forecast
  5. Competitive Landscape………………………………………………………….…………
    1. Major Players
    2. Products in Pipeline
  6. Key Company Profiles………………………………………………………………………
    1. Eli Lilly Company overview, Product & Services, Strategies & Financials
    2. Johnson and Johnson Company overview, Product & Services, Strategies & Financials
    3. Astellas Pharma Company, Product & Services, Strategies & Financials
  7. Healthcare Policies and Regulatory Landscape…………………………..………….
    1. Policy changes and Reimbursement scenario
  8. Factors Driving Future Growth…………………………………………………………..
    1. Key Industry Developments
    2. Mergers and Acquisitions
  9. Potential Growth Opportunities………………………………………………………….
    1. Future Opportunities
  10. Conclusion

Market Segmentation

By Drugs

Based on drugs, the market includes biguanides, alpha-glucosidase inhibitors, dopamine-D2 receptor agonists, Sodium-glucose Cotransport -2 (SGLT-2) inhibitor, Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors, sulfonylureas, and meglitinides.

DPP-4 inhibitors segment held the largest market share in 2019. The Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors segment of the oral anti-diabetes drug market was valued at more than USD 7 million in 2019, and it is expected to record a CAGR lesser than 4% during the forecast period (2019-2025). DPP-4 inhibitor drugs are gaining momentum in the market because the products do not seem to have any effect on primary adverse cardiovascular outcomes and risk for heart failure. Besides, they can be used both as a combination therapy with insulin, sulphonylureas, and dipeptidyl peptidase-4 drugs and as a monotherapy, thus, making it a widely used class of drugs. During the forecast period, the DPP-4 inhibitors segment is expected to witness constant growth rate, due to the introduction of new drugs that have improved efficacy, like glucagon-like peptide (GLP-1) and sodium-glucose co-transporter-2 (SGLT-2) inhibitors. The segment is still expected to maintain the largest market share among all oral anti-diabetes drugs market segments.

By Region:

Asia-Pacific leading the oral anti-diabetes drugs market. Currently, North America holds the major share in the oral anti-diabetes drugs market. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period. This is due to the high prevalence of diabetes in this region, which caused consequent adverse health and economic consequences. The rates of newly diagnosed cases of Type 1 and Type 2 diabetes are increasing among the youth in the Asia-Pacific region. In 2019, China and India, around 123.6 million people and 76.79 million people, respectively, are living with diagnosed diabetes. Moreover, an increase in the launch of new drugs with improved efficacy and high reimbursement for medicines is expected to have a positive impact on the oral anti-diabetes drug market. The increasing incidence and prevalence of diabetes and the increasing healthcare expenditure in the Asia-Pacific countries are an indication of the increasing usage of oral anti-diabetes drugs.

Top Major Players

The oral anti-diabetes drug market is consolidated, with few major manufacturers having a global market presence, while the remaining manufacturers are confined to the other local or regional markets. Companies are focusing on innovations in diabetes drugs. For instance, Oramed is performing research on the new molecule ORMD-0801, which is the first oral insulin capsule that has the most convenient and safest way to deliver insulin therapy. This drug is expected to be a game-changer in the insulin and oral anti-diabetes drugs markets. The major players are Eli Lilly, J&J, Astellas Pharma, AstraZeneca and Sanofi.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements